Advertisement

Journal of autism and childhood schizophrenia

, Volume 2, Issue 4, pp 343–358 | Cite as

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children

  • Magda Campbell
  • Barbara Fish
  • Raphael David
  • Theodore Shapiro
  • Patrick Collins
  • Celedonia Koh
Article

Abstract

A controlled study of triiodothyronine (T3), a hormone with CNS effects and stimulating properties, is reported in detail and discussed. Twelve of the 16 subjects (13 boys and 3 girls ranging in age from 3 to 6 years) were psychotic (10 schizophrenic and 2 autistic), 2 had chronic organic brain syndromes (Turner's and Klinefelter's, both with withdrawing reaction) and 2 were nonpsychotic (withdrawing and hyperkinetic reactions). Optimal daily doses of T3 ranged from 12.5 to 75 mcg, while those of dextroamphetamine, used as control, from 1.25 to 10 mg. Nonblind evaluations indicated marked improvement on T3 in 11 children, slight in 3, and deterioration in one. Blind ratings indicated statistically significant improvement in overall symptomatology (p⩽0.01). While dextroamphetamine yielded poor responses in all diagnostic categories, T3 had antipsychotic and stimulating effects. T3 is viewed as an agent that is potentially effective in the treatment of childhood schizophrenia.

Keywords

Schizophrenia Poor Response Marked Improvement Diagnostic Category Triiodothyronine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anton-Tay, F., & Wurtman, R. J. Brain monoamines and endocrine function. In L. Martini & W. F. Ganong (Eds.),Frontiers in neuroendocrinology. London: Oxford Univeristy Press, 1971.Google Scholar
  2. Balázs, R., Kovács, S., Cocks, W. A., Johnson, A. L., & Eayrs, J. T. Effect of thyroid hormone on the biochemical maturation of rat brain: Postnatal cell formation.Brain Research, 1971,25, 555–570.PubMedGoogle Scholar
  3. Campbell, M., Fish, B., David, R., Shapiro, T., & Koh, C. Triiodothyronine treatment in psychotic and nonpsychotic children under six years.Archives of General Psychiatry, 1973, in press.Google Scholar
  4. Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., & Koh, C. Lithium and chlorpromazine: A controlled crossover study of hyperactive severly disturbed children.Journal of Autism and Childhood Schizophrenia, 1972,2, 234–263.PubMedGoogle Scholar
  5. Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Thiothixene in young disturbed children. A pilot study.Archives of General Psychiatry, 1970,23, 70–72.PubMedGoogle Scholar
  6. Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Study of molindone in disturbed preschool children.Current Therapeutic Research, 1971,13, 28–33. (a)PubMedGoogle Scholar
  7. Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Imipramine in preschool autistic and schizophrenic children.Journal of Autism and Childhood Schizophrenia, 1971,1, 267–282. (b)PubMedGoogle Scholar
  8. Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Acute responses of schizophrenic children to a sedative and a “stimulating” neuroleptic: A pharmacologic yardstick.Current Therapeutic Research, 1972,14, 759–766.PubMedGoogle Scholar
  9. Campbell, M., & Hersh, S. P. Observations on the vicissitudes of aggression in two siblings.Journal of Autism and Childhood Schizophrenia, 1971,1, 398–410.PubMedGoogle Scholar
  10. Campbell, M., Wolman, S. R., Breuer, H., Miller, F. T., & Perlman, B. B. Klinefelter's syndrome in a three-year-old severely disturbed child.Journal of Autism and Childhood Schizophrenia, 1972,2, 34–48.PubMedGoogle Scholar
  11. Coleman, M. Serotonin levels in infant hypothyroidism.Lancet, 1970,7668, 365.Google Scholar
  12. Danziger, L. Thyroid therapy of schizophrenia.Diseases of the Nervous System. 1958,19, 373–378.PubMedGoogle Scholar
  13. Danziger, L., & Elmergreen, G. L. Mechanism of periodic catatonia.Confinia Neurologica, 1958,18, 159–166.PubMedGoogle Scholar
  14. Danziger, L., & Kindwall, J. A. Thyroid therapy in some mental disorders.Diseases of the Nervous System, 1953,14, 3–13.PubMedGoogle Scholar
  15. Durell, J., Libow, L. S., Kellam, S. G., & Shader, R. I. Interrelationships between regulation of thyroid gland function and psychosis.Association for Research in Nervous and Mental Diseases. 1963,43, 387–399.Google Scholar
  16. Eayrs, J. T. Developmental relationships between brain and thyroid. In R. P. Michael (Ed.),Endocrinology and human behavior. London: Oxford University Press, 1968.Google Scholar
  17. Fish, B. Methodology in child psychopharmacology. In D. H. Efron, J. O. Cole, J. Levine, & J. R. Wittenborn (Eds.),Psychopharmacology, review of progress (Public Health Service Publication No. 1836). Washington, D.C.: Government Printing Office, 1968.Google Scholar
  18. Fish, B. The “one child, one drug” myth of stimulants in hyperkinesis. Importance of diagnostic categories in evaluating treatment.Archives of General Psychiatry, 1971,25, 193–203.Google Scholar
  19. Fish, B., Campbell, M., Shapiro, T., & Floyd, A., Jr. Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: The value of less sedative antipsychotic agents.Current Therapeutic Research, 1969,11, 589–595. (a)PubMedGoogle Scholar
  20. Fish, B., Campbell, M., Shapiro, T., & Floyd, A., Jr. Schizophrenic children treated with methysergide (Sansert).Diseases of the Nervous System, 1969,30, 534–540. (b)PubMedGoogle Scholar
  21. Fish, B., Shapiro, T., & Campbell, M. Long term prognosis and the response of schizophrenic children to drug therapy: A controlled study of trifluoperazine.American Journal of Psychiatry, 1966,123, 32–39.PubMedGoogle Scholar
  22. Fish, B., Shapiro, T., Campbell, M., & Wile, R. A classification of schizophrenic children under five years.American Journal of Psychiatry, 1968,124, 1415–1423.PubMedGoogle Scholar
  23. Flach, F. F., Celian, C. I., & Rawson, R. W. Treatment of psychiatric disorders with triiodothyronine.American Journal of Psychiatry, 1958,114, 841–842.PubMedGoogle Scholar
  24. Gjessing, R. Disturbances of somatic functions in catatonia with a periodic course, and their compensation.Journal of Mental Science, 1938,84, 608–621.Google Scholar
  25. Gjessing, R. Beitrage zur Somatologie der Periodischen Katatonie.Archive fur Psychiatrie und Zeitschrift Neurologie, 1953,191, 191–326.Google Scholar
  26. Greulich, W. W., & Pyle, S. I.Radiographic atlas of skeletal development of the hand and wrist. (2nd ed.) Stanford, Calif.: Stanford University Press, 1959.Google Scholar
  27. Hoskins, R. G.The biology of schizophrenia. New York: Norton & Co., 1946.Google Scholar
  28. McCann, S. Mechanism of action of hypothalamic-hypophyseal stimulating and inhibiting hormones. In L. Martini & W. F. Ganong (Eds.),Frontiers in neuroendocrinology. London: Oxford University Press, 1971.Google Scholar
  29. Rey, J. H. Metabolism in recurrent schizophrenia. In D. Richter (Ed.),Schizophrenia, somatic aspects. New York: Pergamon Press, 1957.Google Scholar
  30. Ritvo, E. R., Yuwiler, A., Geller, E., Ornitz, E. M., Saeger, K., & Plotkin, S. Increased blood serotonin and platelets in early infantile autism.Archives of General Psychiatry, 1970,23, 566–572.PubMedGoogle Scholar
  31. Schain, R. J., & Freedman, D. X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.Journal of Pediatrics, 1961,58, 315–320.PubMedGoogle Scholar
  32. Sherwin, A. C., Flach, F. F., & Stokes, P. E. Treatment of psychoses in early childhood with triiodothyronine.American Journal of Psychiatry, 1958,115, 166–167.PubMedGoogle Scholar

Copyright information

© Scripta Publishing Company 1972

Authors and Affiliations

  • Magda Campbell
    • 1
  • Barbara Fish
    • 1
  • Raphael David
    • 1
  • Theodore Shapiro
    • 1
  • Patrick Collins
    • 1
  • Celedonia Koh
    • 1
  1. 1.New York University Medical CenterNew York

Personalised recommendations